DIAPH1 and neurodegenerative disease: Recent studies have shown that in animal models of neurodegenerative diseases, the pharmacological or genetic blocking of Diaph1 attenuates inflammation and Diaph1-associated perturbations [8,9,14,68,69,70,71,72].